Optimi Well being Indicators Psilocybin Provide Settlement With Halucenex Life Sciences Inc.

VANCOUVER, British Columbia, Could 27, 2022 (GLOBE NEWSWIRE) — Optimi Well being Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Firm”), a homegrown, Canadian firm producing pure, scalable, and accessible mushroom formulations for transformational human experiences, is happy to announce that it has entered right into a provide settlement with Halucenex Life Sciences Inc. (“Halucenex”), a completely owned subsidiary of Creso Pharma of Australia (ASX: CPH). Halucenex relies in Windsor, Nova Scotia and is a life sciences firm targeted on researching novel psychedelic compounds, creating and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets, and conducting medical trials on the medical advantages of psychedelic drugs.

Moreover, Optimi needs to verify that the provision settlement pertains to the whole lot of the Firm’s not too long ago harvested first batch of psilocybe cubensis mushrooms at its Princeton, British Columbia facility. The mushrooms shall be provided to Halucenex within the type of entire, dried mushroom fruiting our bodies.

“This primary provide settlement, coming so quickly after our first full cultivation cycle, is a strong affirmation of our resolution to pursue the event of pure, GMP psilocybin,” stated Invoice Ciprick, CEO of Optimi. “From this preliminary proof-of-concept batch, our cultivation crew will proceed to scale our operations to satisfy the calls for of the sector, domestically and internationally with licensed entities and for particular person sufferers inside Canada in response to the phrases of the Particular Entry Program.”

Halucenex CEO, Invoice Fleming, says the settlement with Optimi is one each corporations will profit from.

“We’re very excited to be transferring ahead on this provide settlement with the crew at Optimi Well being,” stated Fleming. “Amongst our high priorities within the growth of a psychedelic-assisted psychotherapeutic mannequin for circumstances corresponding to nervousness and post-traumatic stress dysfunction has been to safe a secure, constant provide of GMP psilocybin.”

Approved events focused on buying Optimi psilocybin and useful mushroom merchandise ought to ship an e-mail to [email protected] the place a member of the gross sales crew will reply inside 24 hours.


Optimi Well being Inc. is a homegrown, Canadian success story producing and supplying pure, EU-GMP grade psilocybin and useful mushrooms that target the well being and wellness markets. Constructed with the aim to provide scalable, pure mushroom formulations for transformational human experiences, the Firm’s objective is to be the primary trusted, compassionate provider of secure, pure GMP grade psilocybin internationally. With a vertically built-in method, Optimi intends to domesticate, extract, course of and distribute prime quality useful and psychedelic mushroom merchandise at its two amenities comprising a complete of 20,000 sq. ft in Princeton, British Columbia.

To totally examine the science of mushrooms, the Firm has acquired a analysis exemption beneath Well being Canada Meals and Drug Laws (FDR) for using psilocybin and psilocin for scientific functions through its wholly owned subsidiary Optimi Labs Inc. Optimi has additionally been granted a seller’s license beneath Canada’s Narcotic Management Laws governing possession, distribution, sale, laboratory evaluation of and analysis and growth of psilocybin and psilocin formulations. Optimi is dedicated to skilled cultivation and high quality manufacturing topic to and in accordance with the phrases of all relevant legal guidelines and governing rules to make sure secure, superior Canadian fungi manufacturing.

Optimi was not too long ago granted an modification to its Supplier’s Licence by Well being Canada, permitting the Firm to own a quota of as much as 5000kg of dried psilocybin mushrooms – the equal of 10kg of psilocybin – and 100g of psilocin.


Halucenex operates a 6000 sq ft medical facility in Windsor, Nova Scotia with six remedy rooms and a safe laboratory devoted to performing psychedelic-assisted psychotherapy and medical analysis. Halucenex intends to take care of management over all features of the product growth course of – mycological analysis, extraction expertise, and artificial formulation in addition to drug supply applied sciences, psychedelic-assisted psychotherapy and regulatory affairs.

Clinically, Halucenex is concentrated on researching psilocybin, psilocybin-derivatives, and different psychedelic drugs for the needs of treating shoppers affected by PTSD and nervousness utilizing its complete psilocybin-assisted psychotherapy remedy mannequin. Halucenex is dedicated to advancing the science round using psilocybin in psychedelic-assisted psychotherapy by:

For extra info or to request an interview, please contact:

Michael Kydd
Media & Stakeholder Relations Advisor
Electronic mail: [email protected]
Telephone: +1 (902) 880 6121


This information launch comprises ahead‐wanting statements and ahead‐wanting info inside the which means of Canadian securities laws (collectively, “ahead‐wanting statements”) that relate to Optimi’s present expectations and views of future occasions. Any statements that categorical, or contain discussions as to, expectations, beliefs, plans, aims, assumptions or future occasions or efficiency (usually, however not all the time, by way of using phrases or phrases corresponding to “will doubtless end result,” “are anticipated to,” “expects,” “will proceed,” “is anticipated,” “anticipates,” “believes,” “estimated,” “intends,” “plans,” “forecast,” “projection,” “technique,” “goal,” and “outlook”) usually are not historic details and could also be ahead‐wanting statements and should contain estimates, assumptions and uncertainties which may trigger precise outcomes or outcomes to vary materially from these expressed in such ahead‐wanting statements. No assurance could be on condition that these expectations will show to be appropriate and such ahead‐wanting statements included on this information launch shouldn’t be unduly relied upon. These statements communicate solely as of the date of this information launch. Specifically and with out limitation, this information launch comprises ahead‐ wanting statements pertaining to actions proposed to be performed beneath the Firm’s seller’s license and related enterprise associated to psilocybin and psilocin and Optimi’s plans, focus and aims.

Ahead‐wanting statements are based mostly on quite a few assumptions and are topic to quite a few dangers and uncertainties, lots of that are past Optimi’s management, which may trigger precise outcomes and occasions to vary materially from these which can be disclosed in or implied by such ahead‐wanting statements. Such dangers and uncertainties embody, however usually are not restricted to, the impression and development of the COVID‐19 pandemic and different components set forth beneath “Ahead‐Wanting Statements” and “Threat Elements” within the Firm’s Annual info Kind dated January 12, 2022, and different steady disclosure filings accessible beneath Optimi’s profile at www.sedar.com. Optimi undertakes no obligation to replace or revise any ahead‐wanting statements, whether or not on account of new info, future occasions or in any other case, besides as could also be required by regulation. New components emerge every so often, and it isn’t attainable for Optimi to foretell all of them or assess the impression of every such issue or the extent to which any issue, or mixture of things, might trigger outcomes to vary materially from these contained in any ahead‐wanting assertion.

Any ahead‐wanting statements contained on this information launch are expressly certified of their entirety by this cautionary assertion.

Pictures accompanying this announcement can be found at


Keep related with us on social media platform for on the spot replace click on right here to hitch our  Twitter, & Fb